Cost effectiveness of cervical cancer prevention strategies in Indonesia

Background: The development of several HPV-related control techniques for the prevention cervical cancer followed identification a link between high-risk human papillomavirus (HPV) infection and occurrence cancer. Objective: objective current study was to determine how cost-effective different screening programs HPV vaccinations in Indonesia. Methods: lifetime costs effects vaccination among adolescent girls or with either VIA, Papanicolaou, DNA test at various time intervals hypothetical cohort 30-65 yearsold women were estimated using Markov model based on societal perspective. Results: Based statistics transition probabilities, efficacy vaccination, diagnostic accuracy procedures. findings this study, specifically cost-effectiveness preventing revealed that each woman’s cost $16. amount disease-adjusted life years (DALYs) may be saved $213, averted per death $1.438. Conclusion: Early IVA method has net $576 qualityadjusted $18 examination woman, $1,532 preventable death. When group teenage who received HPV, vaccine reaches age 30, VIA frequency should decided depending cohort’s overall coverage.